ORANGE CITY, Iowa, March 3, 2025 /PRNewswire/ — Creative Science, a CIMA Animal Health company, and a leader in veterinary medical solutions, proudly announces the acquisition of Infiniti Medical LLC and its subsidiary Orthomed UK Ltd, two globally recognized brands specializing in veterinary interventional radiology, cardiology, soft tissue surgery, and orthopedics. This strategic acquisition strengthens Creative Science’s commitment to providing cutting-edge solutions that enhance the standard of care in veterinary medicine.

Creative Science is stepping up to support pet owners, veterinary clinics, and shelters affected by the recent shutdown of the Save This Life (STL) pet microchip registry. (PRNewsfoto/Creative Science)

Infiniti Medical products maintain a leading position in the global animal health tech industry and are sold to veterinarians worldwide. With a foundation in Silicon Valley, Infiniti has led the way in developing groundbreaking veterinary technologies and devices, from its pioneering Vet Stent solutions to advancements in diagnostics, telemedicine, and digital health. Orthomed, renowned for its gold-standard orthopedic implants and instruments, has been a trusted provider of precision-engineered veterinary products for over 15 years, setting new benchmarks for surgical excellence.

“This acquisition represents an exciting opportunity to expand our impact on veterinary medicine,” said Lynn Snodgrass, CEO of CIMA Animal Health. “Infiniti Medical and Orthomed are trailblazers in their respective fields, and by joining forces, we can accelerate innovation and provide even greater value to veterinary professionals worldwide.”

The integration of Infiniti Medical and Orthomed into Creative Science will enable the combined companies to enhance product offerings, streamline manufacturing, and expand educational initiatives for veterinary surgeons. Orthomed’s extensive CPD training programs and Infiniti’s commitment to industry leading medical device solutions align seamlessly with Creative Science’s mission to support veterinarians with the best possible tools and knowledge.

Jared Finegold, CEO of Infiniti Medical, expressed enthusiasm for the partnership: “Infiniti Medical was founded on the belief that advanced technology could revolutionize veterinary medicine. By partnering with Creative Science, we will continue to scale our efforts, invest further in veterinary medical device innovations, and accelerate our development of cutting-edge technologies and training solutions for veterinarians across the globe.”

Advisors

Hyde Park Capital Advisors, led by Managing Director Craig Lawson, served as the exclusive financial advisor to Infiniti Medical for this transaction.